Status: Recruiting
Efficacy and Safety of Tozorakimab in Patients Hospitalised for Viral Lung Infection Requiring Supplemental Oxygen
The purpose of this study is to evaluate the effect of tozorakimab, as an add-on to SoC in patients with viral lung infection requiring supplemental oxygen, on the prevention of death or progression to IMV/ECMO.
Participants needed: 3,527
Trial details
Phase: Phase 3Age: 18+Biological sex: AllType: InterventionalSponsor: AstraZenecaUpdated: Aug 28, 2026Locations: 468
Eligibility criteria
Adult participants ≥ 18 years old at the time of signing the informed consent fo... [+2]
Known fungal or parasitic lung infection, aspiration lung infection, lung absces... [+2]